Fullerton Health, a Singapore-based healthcare solutions provider operating in nine markets across Asia-Pacific, has announced that Japan's Mitsubishi Corporation has acquired a strategic minority stake in the Company.
This partnership marks a significant milestone in Fullerton Health's growth journey, enabling greater shareholder alignment as the company sharpens its focus on regional growth and accelerates its vision for integrated, digitally enabled care and service.
This investment, which concludes a series of minority investments including that of Far East Drug's, will propel Fullerton Health's continued expansion in existing markets – particularly in Singapore, Indonesia and the Philippines where its presence is strongest – while actively pursuing strategic entry into new ones across the region.
The company will leverage its robust footprint as well as digital and AI capabilities to roll out regional and local solutions on a fully integrated platform. Fullerton Health combines clinical excellence with tailored corporate healthcare programs, medical advisory expertise, and digital innovation to meet the diverse needs of its clients.
